160 related articles for article (PubMed ID: 35015151)
21. Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer.
Shin JS; Suh KW; Oh SY
J Surg Oncol; 2015 Nov; 112(6):654-7. PubMed ID: 26437893
[TBL] [Abstract][Full Text] [Related]
22. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].
Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284
[TBL] [Abstract][Full Text] [Related]
23. Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma.
Yeh CC; Kao HK; Huang Y; Tsai TY; Young CK; Hung SY; Lu CY; Chang KP
Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612318
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
[TBL] [Abstract][Full Text] [Related]
25. Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients.
Jakubowska K; Koda M; Grudzińska M; Kańczuga-Koda L; Famulski W
World J Gastroenterol; 2020 Aug; 26(31):4639-4655. PubMed ID: 32884222
[TBL] [Abstract][Full Text] [Related]
26. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
[TBL] [Abstract][Full Text] [Related]
27. The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer.
Kubo H; Murayama Y; Arita T; Kuriu Y; Nakanishi M; Otsuji E
World J Surg; 2016 Nov; 40(11):2796-2802. PubMed ID: 27307087
[TBL] [Abstract][Full Text] [Related]
28. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer.
Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S
J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
[No Abstract] [Full Text] [Related]
30. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
31. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Cunningham D; Mudan S
Med Oncol; 2014 Oct; 31(10):239. PubMed ID: 25218270
[TBL] [Abstract][Full Text] [Related]
32. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients With Colorectal Cancer After Surgical Resection.
Kusunoki K; Toiyama Y; Okugawa Y; Yamamoto A; Omura Y; Ohi M; Araki T; Kusunoki M
Dis Colon Rectum; 2020 Sep; 63(9):1242-1250. PubMed ID: 33216495
[TBL] [Abstract][Full Text] [Related]
33. A New Prognostic Index in Young Breast Cancer Patients.
Demir H; Demirci A; Eren SK; Beypinar I; Davarcı SE; Baykara M
J Coll Physicians Surg Pak; 2022 Jan; 32(1):86-91. PubMed ID: 34983154
[TBL] [Abstract][Full Text] [Related]
34. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer.
Topkan E; Kucuk A; Ozkan EE; Ozturk D; Besen AA; Mertsoylu H; Pehlivan B; Selek U
Discov Oncol; 2023 Dec; 14(1):230. PubMed ID: 38091179
[TBL] [Abstract][Full Text] [Related]
35. The C-reactive protein to albumin ratio predicts postoperative complications in oldest-old patients with colorectal cancer.
Hashimoto S; Tominaga T; Nonaka T; Hamada K; Araki M; Takeshita H; Fukuoka H; Wada H; To K; Komatsu H; Tanaka K; Sawai T; Nagayasu T
Int J Colorectal Dis; 2020 Mar; 35(3):423-431. PubMed ID: 31897648
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients.
Gambichler T; Stang A; Mansour R; Scheel CH; Nick C; Abu Rached N; Becker JC; Susok L
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139570
[TBL] [Abstract][Full Text] [Related]
37. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients.
Yasui K; Shida D; Nakamura Y; Ahiko Y; Tsukamoto S; Kanemitsu Y
Br J Cancer; 2021 Mar; 124(5):933-941. PubMed ID: 33257844
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of the preoperative prognostic nutritional index in oldest-old patients with colorectal cancer.
Tominaga T; Nonaka T; Hisanaga M; Fukuda A; Tanoue Y; Yoshimoto T; Hidaka S; Sawai T; Nagayasu T
Surg Today; 2020 May; 50(5):449-459. PubMed ID: 31720800
[TBL] [Abstract][Full Text] [Related]
39. Systemic Inflammation-Immune Status Predicts Survival in Stage III-N2 Non-Small Cell Lung Cancer.
Wang J; Hui Z; Men Y; Kang J; Sun X; Deng L; Zhai Y; Wang W; Bi N; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Wang L; Zhao J
Ann Thorac Surg; 2019 Dec; 108(6):1701-1709. PubMed ID: 31400325
[TBL] [Abstract][Full Text] [Related]
40. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
